The global plant-based ingredient and pharmaceutical supplier Roquette has revealed its acquisition of the hard capsule and oral dosage specialists Qualicaps.
Despite a range of new and unique dosage forms entering the market, capsules are still the preferred format for global consumers, with innovative new capsule technologies giving brands the opportunity to stand out in a crowded marketplace, says Lonza.
Treating the gut to a blend of probiotics and prebiotics combined with chicory-rich ingredient inulin may enhance the recovery of patients with long Covid, a study thinks.
Global plant-based ingredient pioneer Roquette has announced the launch of its ready-to-use, pharmaceutical grade solution for vegetarian softgel capsule formulation, named LYCAGEL Premix.
Researchers have harnessed the power of bioluminescent imaging to better assess the health benefits of prebiotics and probiotics via a capsule that measures enzyme activity.
Lonza is to sell off two European sites to NextPharma in a deal that gives the contract development and manufacturing firm facilities to work with lipid oral dosage forms for the nutrition and pharma markets.
Lonza and Glanbia Performance Nutrition have announced a collaboration which sees direct-to-consumer brand Body&Fit expand using Lonza’s DUOCAP technology and ingredients.
Roquette has launched a market-first pea starch technology, named LYCAGEL, which it claims will take vegetarian softgel formulations to the next level.
Lonza’s €78.2m ($93m) investment in its Capsules and Health Ingredients (CHI) Division will increase the capsule production capacity by 15%, according to company executives.
2020 may not seem to be a good time for being a year one start-up, but increased consumer interest in supplements and immunity is a rising tide that is raising all boats, says the CEO of Nouri.